PGR and neoplasm: The two patients with metastatic breast cancer who had experienced an objective response to breast cancer-specific modulation frequencies had tumours that over-expressed oestrogen receptor (ER+) and progesterone receptor (PR+), but did not over-express ERBB2 (ERBB2−) (Barbault et al, 2009).